Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2014 08:00 ET | Source: Karyopharm Therapeutics

Karyopharm Expands Global Presence With European Subsidiary

NEWTON, Mass., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that it has expanded its operational footprint...
September 29, 2014 08:00 ET | Source: Karyopharm Therapeutics

Karyopharm Announces Clinical Data for Selinexor (KPT-330) in Advanced Solid Tumors

- Selinexor Demonstrates Clinical Activity in Prostate Cancer and other Solid Tumors - - Data from Ongoing Phase 1 Clinical Study Presented at ESMO 2014 - - Webcast Scheduled for Monday,...
September 25, 2014 17:16 ET | Source: Karyopharm Therapeutics

Karyopharm to Host Conference Call to Discuss Selinexor (KPT-330) Data Presented at ESMO 2014

- Phase 1 Clinical Data in Prostate Cancer and Other Solid Tumors - - Conference Call and Interactive Webcast Scheduled for Monday, September 29, 2014 at 4:30pm ET - NEWTON, Mass., Sept. 25,...
September 09, 2014 06:30 ET | Source: Karyopharm Therapeutics

Karyopharm Announces Three Clinical Data Presentations at ESMO 2014

NEWTON, Mass., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that clinical and preclinical data for its lead...
August 08, 2014 07:30 ET | Source: Karyopharm Therapeutics

Karyopharm Appoints Justin Renz Executive Vice President and Chief Financial Officer

NEWTON, Mass., Aug. 8, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class...
August 07, 2014 16:17 ET | Source: Karyopharm Therapeutics

Karyopharm to Present at the Wedbush 2014 Life Sciences Management Access Conference

NEWTON, Mass., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class...
August 07, 2014 07:00 ET | Source: Karyopharm Therapeutics

Karyopharm Therapeutics Reports Second Quarter Financial Results for 2014

NEWTON, Mass., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class...
August 01, 2014 16:05 ET | Source: Karyopharm Therapeutics

Karyopharm to Host Second Quarter 2014 Earnings Call on August 7, 2014

NEWTON, Mass., Aug. 1, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on nuclear transport targets, today announced that it will...
June 30, 2014 08:00 ET | Source: Karyopharm Therapeutics

Karyopharm Announces Full Exercise of Underwriters Option to Purchase Additional Shares in Public Offering of Common Stock

NATICK, Mass., June 30, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced that the underwriters of its previously announced public offering of common stock have...
June 26, 2014 22:00 ET | Source: Karyopharm Therapeutics

Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock

NATICK, Mass., June 26, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced the pricing of its underwritten public offering of 2,647,247 shares of its common stock at a...